PROTECT MULTI AKTIENANLEIHE - BASF/MERCK/BAYER Stock

Certificat

DE000VM8M5G9

Market Closed - Boerse Frankfurt Warrants 13:42:12 2024-05-21 EDT
101.4 EUR -0.73% Intraday chart for PROTECT MULTI AKTIENANLEIHE - BASF/MERCK/BAYER
Current month+1.80%
1 month+3.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 101.4 -0.73%
24-05-20 102.2 0.00%
24-05-17 102.2 -0.12%
24-05-16 102.3 -0.16%
24-05-15 102.4 +0.93%

Real-time Boerse Frankfurt Warrants

Last update May 21, 2024 at 01:42 pm

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VM8M5G
ISINDE000VM8M5G9
Date issued 2024-02-05
Strike 148.6
Maturity 2025-03-21 (304 Days)
Parity 0.15 : 1
Emission price 100
Emission volume N/A
Settlement les deux
Currency EUR

Technical Indicators

Highest since issue 102.5
Lowest since issue 97.69

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
165.7 EUR
Average target price
182.3 EUR
Spread / Average Target
+10.03%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW